Multisystem Inflammatory Syndrome in Children — Initial Therapy and Outcomes

BACKGROUND: The assessment of real-world effectiveness of immunomodulatory medications for multisystem inflammatory syndrome in children (MIS-C) may guide therapy. METHODS: We analyzed surveillance data on inpatients younger than 21 years of age who had MIS-C and were admitted to 1 of 58 U.S. hospit...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:N Engl J Med
Asıl Yazarlar: Son, Mary Beth F., Murray, Nancy, Friedman, Kevin, Young, Cameron C., Newhams, Margaret M., Feldstein, Leora R., Loftis, Laura L., Tarquinio, Keiko M., Singh, Aalok R., Heidemann, Sabrina M., Soma, Vijaya L., Riggs, Becky J., Fitzgerald, Julie C., Kong, Michele, Doymaz, Sule, Giuliano, John S., Keenaghan, Michael A., Hume, Janet R., Hobbs, Charlotte V., Schuster, Jennifer E., Clouser, Katharine N., Hall, Mark W., Smith, Lincoln S., Horwitz, Steven M., Schwartz, Stephanie P., Irby, Katherine, Bradford, Tamara T., Maddux, Aline B., Babbitt, Christopher J., Rowan, Courtney M., McLaughlin, Gwenn E., Yager, Phoebe H., Maamari, Mia, Mack, Elizabeth H., Carroll, Christopher L., Montgomery, Vicki L., Halasa, Natasha B., Cvijanovich, Natalie Z., Coates, Bria M., Rose, Charles E., Newburger, Jane W., Patel, Manish M., Randolph, Adrienne G.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Massachusetts Medical Society 2021
Konular:
Original Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC8220972/
https://ncbi.nlm.nih.gov/pubmed/34133855
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1056/NEJMoa2102605
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller